DUBLIN, Sept. 25, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/kvxgmg/investigation) has announced the addition of the "Investigation Report on China's Ornidazole Market, 2010-2019" report to their offering.
Originally developed by Hoffer.M, ornidazole got US patent on May.25, 1969. Later, the patent was transferred to Hoffmann- LaRocheandCo that marketed ornidazole under the trade name of Tiberal in Germany, France, Italy, Switzerland, Australia and Sweden during the period of 1977- 1983. Coming as tablet, capsule, injection, ornidazole can be used to treat bacterial vaginosis, endometritis, ovarian cyst and pelvis soft tissue infection.
Ornidazole products available in the Chinese market all come from over ten local companies. According to this market survey, Sichuan Kelun Pharmaceutical Co., Ltd, Xi'an Wanlong Pharmaceutical Co., Ltd, Shaanxi Jinyu Pharmaceutical Co., Ltd and Nanjing Sanhome Pharmaceutical Co., Ltd occupy the market, among which Sichuan Kelun Pharmaceutical Co., Ltd had the largest market share of over 30% for sales value in 2014.
The market size of ornidazole in China grew during the period of 2005- 2011 and then dropped during the period of 2011- 2013 before rising again in 2014. And injection contributing to over 90% of the sales sells best among all dosage forms. As China is a country with a high incidence of infectious disease, ornidazole enjoys good market prospects here.
Key Topics Covered:
1 Related Concepts of Ornidazole
2 Market Profile of Ornidazole in China
3 Survey on Ornidazole Sales in China, 2010-2014
4 Survey on Market Share of Major Ornidazole Manufacturers in China, 2010-2014
5 Survey on Dosage Forms of Ornidazole in China, 2010-2014
6 Reference Price of Ornidazole in Chinese Hospitals in 2014
7 Major Manufacturers of Ornidazole in Chinese Market, 2010-2014
8 Market Outlook of Ornidazole in China, 2015-2019
Companies Mentioned
- Nanjing Sanhome Pharmaceutical Co., Ltd
- Shaanxi Jinyu Pharmaceutical Co., Ltd
- Sichuan Baili Pharmaceutical Co., Ltd
- Sichuan Kelun Pharmaceutical Co., Ltd
- Wuhan Changlian Laifu Pharmaceutical Limited Liability Company
- Xi'an Wanlong Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/kvxgmg/investigation
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article